Abeona Therapeutics
ABEO
12 hedge funds and large institutions have $13.2M invested in Abeona Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
18% less capital invested
Capital invested by funds: $16.1M → $13.2M (-$2.84M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$686K |
| 2 |
Millennium Management
New York
|
+$36.4K |
| 3 |
Morgan Stanley
New York
|
+$3.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$4.31M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$653K |
| 3 |
ES
Equitec Specialists
Chicago,
Illinois
|
-$253K |
| 4 |
DM
Deerfield Management
New York
|
-$72.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$564 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OIM
1
Oracle Investment Management
Greenwich,
Connecticut
| $4.24M | -$4.31M | -53,518 | -50% |
|
|
PA
2
Perceptive Advisors
New York
| $3.92M | – | – | – |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $2.47M | -$653K | -8,110 | -20% |
|
|
DM
4
Deerfield Management
New York
| $1.1M | -$72.4K | -899 | -6% |
|
|
SFM
5
Soros Fund Management
New York
| $785K | – | – | – |
|
|
KCM
6
Knoll Capital Management
Miami,
Florida
| $669K | +$686K | +8,524 | New |
|
|
7
Millennium Management
New York
| $35K | +$36.4K | +452 | New |
|
|
8
Morgan Stanley
New York
| $3K | +$3.22K | +40 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | -$564 | -7 | -29% |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
11
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
AIG
13
American International Group
New York
| $3 | – | – | – |
|
|
ES
14
Equitec Specialists
Chicago,
Illinois
| – | -$253K | -2,930 | Closed |
|
ABEO Hedge Fund Activity: Q1 2015 in Review
12 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2015, worth a combined $13.2M — down 18% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ABEO positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Knoll Capital Management, opening a new position worth an estimated $686K. The largest seller was Oracle Investment Management, cutting an estimated $4.31M.
- 12 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2015, up from 11 in Q4 2014.
- Funds reported $13.2M of Abeona Therapeutics stock for Q1 2015, down 18% quarter-over-quarter.
- 3 funds opened new Abeona Therapeutics positions in Q1 2015 and 2 closed out, a net change of +1 holder.
- The largest Abeona Therapeutics buyer in Q1 2015 was Knoll Capital Management, an estimated $686K added.
- The largest Abeona Therapeutics seller in Q1 2015 was Oracle Investment Management, an estimated $4.31M sold.
Based on aggregated 13F filings for Q1 2015.